Compare Cardinal Health Inc (CAH) vs Nu Holdings Ltd (NU) Price & Performance

Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.

The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.

NU Holdings trades at $13.67, down 0.65% on the day, with strong fundamental performance including 26.72% net income margin and 30.04% ROE. The company shows impressive revenue growth from $3.0B in 2022 to $10.63B in 2025, with technical indicators showing a bullish trend supported by moving averages. Recent approval for banking operations in Mexico with 15 million customers provides significant growth catalyst.

NU presents a compelling growth story with expanding profitability and Latin American market penetration. The stock trades below analyst consensus target of $14.98, offering potential upside, though currency headwinds and credit risks in emerging markets remain concerns. With 54.55% analyst buy ratings and strong cash flow generation, the long-term outlook appears positive despite recent earnings misses.